Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration
- PMID: 31140325
- PMCID: PMC6761595
- DOI: 10.1089/hum.2019.005
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration
Abstract
Degenerative disc disease (DDD) is a primary contributor to low-back pain, a leading cause of disability. Progression of DDD is aided by inflammatory cytokines in the intervertebral disc (IVD), particularly TNF-α and IL-1β, but current treatments fail to effectively target this mechanism. The objective of this study was to explore the feasibility of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) epigenome editing-based therapy for DDD, by modulation of TNFR1/IL1R1 signaling in pathological human IVD cells. Human IVD cells from the nucleus pulposus of patients receiving surgery for back pain were obtained and the regulation of TNFR1/IL1R1 signaling by a lentiviral CRISPR epigenome editing system was tested. These cells were tested for successful lentiviral transduction/expression of deactivated Cas9 fused to Krüppel Associated Box system and regulation of TNFR1/IL1R1 expression. TNFR1/IL1R1 signaling disruption was investigated through measurement of NF-κB activity, apoptosis, and anabolic/catabolic changes in gene expression postinflammatory challenge. CRISPR epigenome editing systems were effectively introduced into pathological human IVD cells and significantly downregulated TNFR1 and IL1R1. This downregulation significantly attenuated deleterious TNFR1 signaling but not IL1R1 signaling. This is attributed to less robust IL1R1 expression downregulation, and IL-1β-driven reversal of IL1R1 expression downregulation in a portion of patient IVD cells. In addition, RNAseq data indicated novel transcription factor targets, IRF1 and TFAP2C, as being primary regulators of inflammatory signaling in IVD cells. These results demonstrate the feasibility of CRISPR epigenome editing of inflammatory receptors in pathological IVD cells, but highlight a limitation in epigenome targeting of IL1R1. This method has potential application as a novel gene therapy for DDD, to attenuate the deleterious effect of inflammatory cytokines present in the degenerative IVD.
Keywords: CRISPR; degenerative disc disease; epigenome editing; gene therapy; inflammation; receptor.
Conflict of interest statement
No competing financial interests exist.
Similar articles
-
Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6, Tumor Necrosis Factor Alpha, and Interleukin 1β Signaling by the Degenerative Intervertebral Disc.Hum Gene Ther. 2019 Sep;30(9):1147-1160. doi: 10.1089/hum.2019.032. Epub 2019 Jun 11. Hum Gene Ther. 2019. PMID: 31056946
-
* CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments.Tissue Eng Part A. 2017 Aug;23(15-16):738-749. doi: 10.1089/ten.TEA.2016.0441. Epub 2017 Feb 28. Tissue Eng Part A. 2017. PMID: 28095751 Free PMC article.
-
CRISPR Epigenome Editing of AKAP150 in DRG Neurons Abolishes Degenerative IVD-Induced Neuronal Activation.Mol Ther. 2017 Sep 6;25(9):2014-2027. doi: 10.1016/j.ymthe.2017.06.010. Epub 2017 Jul 1. Mol Ther. 2017. PMID: 28676344 Free PMC article.
-
A Review of Gene Therapy Delivery Systems for Intervertebral Disc Degeneration.Curr Pharm Biotechnol. 2020;21(3):194-205. doi: 10.2174/1389201020666191024171618. Curr Pharm Biotechnol. 2020. PMID: 31749423 Review.
-
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17. Bioconjug Chem. 2017. PMID: 28263568 Free PMC article. Review.
Cited by 3 articles
-
TRPV4 Inhibition and CRISPR-Cas9 Knockout Reduce Inflammation Induced by Hyperphysiological Stretching in Human Annulus Fibrosus Cells.Cells. 2020 Jul 21;9(7):1736. doi: 10.3390/cells9071736. Cells. 2020. PMID: 32708074 Free PMC article.
-
Gene Therapy Approach for Intervertebral Disc Degeneration: An Update.Neurospine. 2020 Mar;17(1):3-14. doi: 10.14245/ns.2040042.021. Epub 2020 Mar 31. Neurospine. 2020. PMID: 32252149 Free PMC article.
-
Dead Cas Systems: Types, Principles, and Applications.Int J Mol Sci. 2019 Nov 30;20(23):6041. doi: 10.3390/ijms20236041. Int J Mol Sci. 2019. PMID: 31801211 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Medical
-
Research Materials